Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about EED: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
EED is a gene implicated in neurodegeneration research. Key relationships include: regulates, activates, interacts with. Associated with Als, Cancer, Inflammation. Connected to 23 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | EED |
| Full Name | Embryonic Ectoderm Development |
| Chromosome | 11q14.2 |
| Function | encodes a core scaffolding subunit of Polycomb Repressive Complex 2 (PRC2), the multisubunit complex responsible for trimethylation of histone H3 at lysine 27 (H3K27me3). |
| Pathways | Mapk, Microrna, Nf-Kb, Wnt |
| UniProt ID | O75530 |
| Ensembl ID | ENSG00000074266 |
| OMIM | 605984 |
| GeneCards | EED |
| Human Protein Atlas | EED |
| Associated Diseases | neurodegeneration |
| Interactions | Actin, ALZHEIMER, ALZHEIMER DISEASE, AMYLOID, Aβ, COMPLEMENT |
| KG Connections | 127 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
EED["EED (gene)"]
EZH2["EZH2"]
PRC2["PRC2 Complex"]
TNF["TNF-alpha"]
IL6["IL-6"]
NFKB["NF-kappaB Pathway"]
PI3K["PI3K/AKT"]
MAPK["MAPK Pathway"]
WNT["Wnt Pathway"]
CTNNB1["beta-catenin"]
INFLAMMATION["Neuroinflammation"]
ALS["ALS"]
MICRORNAS["miRNAs"]
NEURODEGENERATION["Neurodegeneration"]
EZH2 -->|"forms complex"| PRC2
EED -->|"core component"| PRC2
PRC2 -->|"H3K27me3"| NEURODEGENERATION
TNF -->|"upregulates"| EED
IL6 -->|"upregulates"| EED
INFLAMMATION -->|"activates"| EED
EED -->|"promotes"| INFLAMMATION
EED -->|"regulates"| NFKB
NFKB -->|"feedback"| EED
PI3K -->|"modulates"| EED
EED -->|"controls"| MAPK
EED -->|"suppresses"| WNT
WNT -->|"regulates"| CTNNB1
EED -->|"targets"| CTNNB1
EED -->|"activates"| ALS
MICRORNAS -->|"therapeutic target"| EED
EED -->|"drives"| NEURODEGENERATION
style EED fill:#1a3a4a,stroke:#4fc3f7,color:#e0e0e0
style MICRORNAS fill:#1b5e20,stroke:#4caf50
style INFLAMMATION fill:#ef5350,stroke:#d32f2f
style ALS fill:#7d4200,stroke:#f57c00
style NEURODEGENERATION fill:#7d4200,stroke:#f57c00
style PRC2 fill:#4a1a6b,stroke:#9c27b0
style NFKB fill:#4a1a6b,stroke:#9c27b0| Target | Relation | Type | Str |
|---|---|---|---|
| oxidative stress response | participates_in | pathway | 0.70 |
| Als | activates | disease | 0.65 |
| Cancer | regulates | disease | 0.65 |
| Inflammation | activates | disease | 0.65 |
| Alzheimer | activates | disease | 0.65 |
| ALZHEIMER | activates | gene | 0.60 |
| AMYLOID | activates | gene | 0.60 |
| Actin | activates | protein | 0.60 |
| Aβ | activates | protein | 0.60 |
| microglia | expressed_in | cell_type | 0.60 |
| GRN | associated_with | gene | 0.60 |
| INPP5D | associated_with | gene | 0.60 |
| LILRB2 | associated_with | gene | 0.60 |
| PICALM | associated_with | gene | 0.60 |
| PLCG2 | associated_with | gene | 0.60 |
| PSEN1 | associated_with | gene | 0.60 |
| AND | associated_with | gene | 0.60 |
| SORL1 | associated_with | gene | 0.60 |
| SPI1 | associated_with | gene | 0.60 |
| TMEM106B | associated_with | gene | 0.60 |
| TREM2 | associated_with | gene | 0.60 |
| CR1 | associated_with | gene | 0.60 |
| CD2AP | associated_with | gene | 0.60 |
| ABI3 | associated_with | gene | 0.60 |
| CLU | associated_with | gene | 0.60 |
| phagocytosis | implicated_in | process | 0.60 |
| TAU PATHOLOGY | activates | gene | 0.60 |
| PTK2B | associated_with | gene | 0.60 |
| PHAGOCYTOSIS | associated_with | entity | 0.60 |
| MS4A6A | activates | gene | 0.60 |
| Phagocytosis | associated_with | pathway | 0.60 |
| Amyloid | activates | pathway | 0.60 |
| Complement | activates | pathway | 0.60 |
| MS4A6A | causes | gene | 0.60 |
| CTNNB1 | regulates | gene | 0.60 |
| Microglia | associated_with | cell_type | 0.60 |
| Neuron | activates | cell_type | 0.60 |
| Microrna | regulates | pathway | 0.60 |
| ROS | activates | gene | 0.60 |
| BIN1 | associated_with | gene | 0.60 |
| ADAM17 | associated_with | gene | 0.60 |
| CTSH | associated_with | gene | 0.60 |
| APP | associated_with | gene | 0.60 |
| APOE | associated_with | gene | 0.60 |
| ACE | associated_with | gene | 0.60 |
| ABCA1 | associated_with | gene | 0.60 |
| CTSB | associated_with | gene | 0.60 |
| Rb | associated_with | protein | 0.60 |
| SIGLEC11 | implicated_in | gene | 0.60 |
| Wnt | regulates | pathway | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| ALZHEIMER DISEASE | associated_with | gene | 0.80 |
| AND | associated_with | gene | 0.60 |
| COMPLEMENT | activates | gene | 0.60 |
| ALZHEIMER DISEASE | activates | gene | 0.60 |
| PHAGOCYTOSIS | associated_with | gene | 0.60 |
| PICALM | associated_with | gene | 0.60 |
| SPI1 | associated_with | gene | 0.60 |
| TMEM106B | associated_with | gene | 0.60 |
| TAU PATHOLOGY | activates | gene | 0.60 |
| TNF | regulates | gene | 0.60 |
| PI3K | regulates | gene | 0.60 |
| EZH2 | interacts_with | gene | 0.60 |
| BCL2 | regulates | gene | 0.60 |
| GSK3B | regulates | gene | 0.60 |
| AKT | regulates | gene | 0.60 |
| LRP1 | activates | gene | 0.60 |
| MIRNAS | therapeutic_target | gene | 0.60 |
| NF-KB | regulates | gene | 0.60 |
| IL-6 | regulates | gene | 0.60 |
| INFLAMMATION | activates | gene | 0.60 |
| TNF-Α | regulates | gene | 0.60 |
| GENES | interacts_with | gene | 0.60 |
| CANCER | regulates | gene | 0.60 |
| MICRORNAS | regulates | gene | 0.60 |
| ACE | associated_with | gene | 0.60 |
| ABCA1 | associated_with | gene | 0.60 |
| ABI3 | associated_with | gene | 0.60 |
| ADAM17 | associated_with | gene | 0.60 |
| APOE | associated_with | gene | 0.60 |
| APP | associated_with | gene | 0.60 |
| BIN1 | associated_with | gene | 0.60 |
| CD2AP | associated_with | gene | 0.60 |
| CD33 | associated_with | gene | 0.60 |
| CLU | associated_with | gene | 0.60 |
| CR1 | associated_with | gene | 0.60 |
| CTSB | associated_with | gene | 0.60 |
| CTSH | associated_with | gene | 0.60 |
| PTK2B | associated_with | gene | 0.60 |
| LILRB2 | associated_with | gene | 0.60 |
| PLCG2 | associated_with | gene | 0.60 |
| GRN | associated_with | gene | 0.60 |
| SORL1 | associated_with | gene | 0.60 |
| INPP5D | associated_with | gene | 0.60 |
| PSEN1 | associated_with | gene | 0.60 |
| TREM2 | associated_with | gene | 0.60 |
| TAU | activates | gene | 0.60 |
| AMYLOID | activates | gene | 0.50 |
| ALZHEIMER | activates | gene | 0.50 |
| CLU | co_discussed | gene | 0.50 |
| CR1 | co_discussed | protein | 0.50 |
Hypotheses where this entity is a therapeutic target
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| Epigenetic clocks association with brain aging patterns in older women | exploratory | cognitive impairment and demen | 0.900 | 0.00 | human patients | proposed | N/A |
| TDP-43 mutant mouse model cGAS/STING pathway analysis | validation | amyotrophic lateral sclerosis | 0.900 | 0.00 | TDP-43 mutant mice | proposed | N/A |
| TDP-43 mitochondrial invasion and DNA release via mPTP | exploratory | amyotrophic lateral sclerosis | 0.900 | 0.00 | cultured cells | proposed | N/A |
| TDP-43 mitochondrial invasion and mtDNA release in iPSC motor neurons | exploratory | Amyotrophic Lateral Sclerosis | 0.900 | 0.00 | iPSC-derived motor neurons | proposed | N/A |
| cGAS/STING pathway validation in TDP-43 mutant mice | validation | Amyotrophic Lateral Sclerosis | 0.850 | 0.00 | TDP-43 mutant mice | proposed | N/A |
| cGAMP biomarker analysis in ALS patient spinal cord samples | exploratory | Amyotrophic Lateral Sclerosis | 0.800 | 0.00 | Human ALS patient spinal cord | proposed | N/A |
| TDP-43 pathology prevalence and distribution in AD cases | exploratory | Alzheimer's disease | 0.800 | 0.00 | human postmortem brain tissue | proposed | N/A |
| Cognitive impact of TDP-43 pathology in AD patients | clinical | Alzheimer's disease | 0.700 | 0.00 | human patients | proposed | N/A |
| Proposed experiment from debate on TDP-43 undergoes liquid-liquid phas | falsification | Neurodegeneration | 0.400 | 0.50 | cell_line | proposed | $80,000 |
| s:** - Single-cell RNA-seq to measure editing efficiency across differ | falsification | ALS | 0.400 | 0.50 | cell_line | proposed | $150,000 |
| Alpha-Synuclein SAA Kinetics Study — Biological Staging Backbone for P | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Autophagy and ALS: mechanistic insights and therapeutic implications. [PMID:34057020] | Chua JP, De Calbiac H, Kabashi E, Barmad | Autophagy | 2022 | 2 |
| TDP-43 Pathology in Alzheimer's Disease. [PMID:34930382] | Meneses A, Koga S, O'Leary J, Dickson DW | Mol Neurodegener | 2021 | 2 |
| Protein transmission in neurodegenerative disease. [PMID:32203399] | Peng C, Trojanowski JQ, Lee VM | Nat Rev Neurol | 2020 | 2 |
| TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS [PMID:33031745] | Yu CH, Davidson S, Harapas CR, Hilton JB | Cell | 2020 | 2 |
| N protein of PEDV plays chess game with host proteins by selective autophagy. [PMID:36861818] | Zhai X, Kong N, Zhang Y, Song Y, Qin W, | Autophagy | 2023 | 1 |
| Role of Alpha-Synuclein in Frontotemporal Dementia: Narrative Review. [PMID:41827903] | Bougea A | Cells | 2026 | 0 |
| Changes in Circulating Levels of miR-30b During Minipuberty and Puberty in Girls [PMID:40899010] | Albrechtsen HM, Saritas G, Winge SB, Mai | J Clin Endocrinol Metab | 2026 | 0 |
| Epigenetics in chronic rhinosinusitis. [PMID:41442742] | Kumar N, Brar T, Lal D | Curr Opin Otolaryngol Head Nec | 2026 | 0 |
| Extracellular vesicles in type 2 diabetes exhibit elevated miR-155 cargo and Ann [PMID:41786286] | Jackson G, Islam H, de Souza Teixeira AA | Life Sci | 2026 | 0 |
| Decoding microRNA-Protein Interaction Networks in Alzheimer's Disease: Molecular [PMID:41918207] | Mishra R, Gupta JK | Curr Alzheimer Res | 2026 | 0 |
| Di-2-ethylhexylphthalate-induced miR155-5P promotes placental ferroptosis. [PMID:41937013] | Gu X, Sun F, Li Y, Yang S, Li Y | Int J Biol Macromol | 2026 | 0 |
| Extracellular Vesicles in Obesity: From Pathophysiological Mediators to Therapeu [PMID:41977323] | Pavlović N, Todorović P, Maglica M, Kopi | Int J Mol Sci | 2026 | 0 |
| The Genetics of TDP-43 Type C Neurodegeneration: A Whole-Genome Sequencing Study [PMID:41883703] | Nassan M, Ayala I, Sloan J, Bonfitto A, | Neurology. Genetics | 2026 | 0 |
| Computational examination of magainin-I-KL mediated disruption of E. coli biofil [PMID:41724836] | Vinutha AS, Akshay S, Sree Agash SG, Cha | Archives of microbiology | 2026 | 0 |
| Antisense oligonucleotide targeting TARDBP-EGFR splicing axis inhibits progressi [PMID:41540015] | Ni N, Wang M, Yuan Z, Zhang L, Cai J, Du | International journal of oral | 2026 | 0 |
| The cytoplasmic protein YedX is a potent inhibitor of CsgA amyloid assembly in E [PMID:41581877] | Gurnani B, Jain N | The Journal of biological chem | 2026 | 0 |
| Decoding microRNA-Protein Interaction Networks in Alzheimer's Disease: Molecular [PMID:41918207] | Mishra R, Gupta JK | Current Alzheimer research | 2026 | 0 |
| Biofluid biomarkers in Alzheimer's disease and other neurodegenerative dementias [PMID:41639575] | Zetterberg H, Bendlin BB | Nature | 2026 | 0 |
| Correction: Antisense oligonucleotide targeting TARDBP-EGFR splicing axis inhibi [PMID:41775718] | Ni Nan; Wang Moxu; Yuan Zhiran; Zhang Le | International journal of oral | 2026 | 0 |
| Biofilm-Associated Amyloid Proteins Linked with the Progression of Neurodegenera [PMID:40141340] | Singh AA, Khan F, Song M | International journal of molec | 2025 | 0 |
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning EED in their description or question text
Score: 0.733 · molecular neurobiology · 2026-04-17
**Molecular Mechanism and Rationale** The lncRNA-0021/miR-6361 interaction represents a sophisticated regulatory mechan
Score: 0.689 · neurodegeneration · 2026-04-02
## Mechanistic Overview Cross-Seeding Prevention Strategy starts from the claim that modulating TARDBP within the diseas
Score: 0.670 · neuroscience · 2026-04-22
## **Molecular Mechanism and Rationale** The proposed mechanism centers on a catastrophic convergence of lipid homeosta
Score: 0.642 · neurodegeneration · 2026-04-02
## Mechanistic Overview Targeting Bacterial Curli Fibrils to Prevent α-Synuclein Cross-Seeding starts from the claim tha
Score: 0.640 · molecular neurobiology · 2026-04-25
The most likely explanation is a two-factor recognition mechanism: a canonical miRNA seed-complementary site in lncRNA-0
Score: 0.640 · neurodegeneration · 2026-04-22
**Molecular Mechanism and Rationale** The mechanistic target of rapamycin complex 1 (mTORC1) serves as a critical cellu
Score: 0.640 · protein folding · 2026-04-22
**Molecular Mechanism and Rationale** The proposed therapeutic strategy exploits the complementary relationship between
Score: 0.633 · neuroinflammation · 2026-04-14
## **Molecular Mechanism and Rationale** The complement cascade represents a critical immune surveillance system within
Score: 0.630 · neurodegeneration · 2026-04-22
## Mechanistic Overview CX3CR1 Agonism Enhances Microglial Phagocytosis of Extracellular Tau Seeds, Preventing Template-
Score: 0.620 · protein folding · 2026-04-22
**Molecular Mechanism and Rationale** The chaperone-degradation coupling hypothesis centers on the critical interaction
Score: 0.610 · neurodegeneration · 2026-04-21
## Mechanistic Overview Tau Cross-Seeding and Interaction starts from the claim that modulating MAPT within the disease
Score: 0.601 · neuroinflammation · 2026-04-15
## Mechanistic Overview STING Antagonism Prevents Acute-to-Chronic Neuroinflammation Transition via Interruption of IFN-
Score: 0.590 · neurodegeneration · 2026-04-25
Transient Aβ exposure activates local kinase programs, especially CDK5/p25 and possibly GSK3β, that keep tau phosphoryla
Score: 0.590 · neurodegeneration · 2026-04-25
TREM2-activated microglia limit neuritic plaque tau spread around amyloid plaques through enhanced phagocytosis of extra
Score: 0.583 · unknown disease · 2026-04-25
Concise Statement: Progressive failure of autophagy flux in AD neurons produces a cascading epigenetic feedback loop —